$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Antiestrogens and their use in treatment of menopause and osteoporosis 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/535
  • A61K-031/445
  • A61K-031/40
  • A61K-031/19
출원번호 US-0143081 (1988-01-12)
발명자 / 주소
  • Young Ronald L. (Houston TX)
출원인 / 주소
  • BCM Technologies, Inc. (Houston TX 02)
인용정보 피인용 횟수 : 66  인용 특허 : 1

초록

Disclosed is a method for treating menopausal symptoms and treating and preventing osteoporosis, wherein a true antiestrogen is administered and estrogen is not. This treatment is effective for female osteoporosis and can also be used to treat male osteoporosis. Examples of true antiestrogens are cl

대표청구항

A method of treating and preventing bone tissue loss or osteoporosis in a patient, comprising administering a true antiestrogen selected from the group consisting of clomiphene, an isomer of clomiphene, a citrate of clomiphene, a derivative of clomiphene, tamoxifen, nafoxidine, CI-680, CI-628, CN-55

이 특허에 인용된 특허 (1)

  1. Jensen Pamela S. (Camden ME) Comite Florence (New Haven CT), Use of clomiphene to predict fertility in a human female.

이 특허를 인용한 특허 (66)

  1. Pickar, James H; Komm, Barry S, 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations.
  2. James Harrison Pickar ; Barry Samuel Komm, 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations.
  3. Holick, Michael F.; Kanis, John, Androgen derivatives and uses thereof.
  4. Holick, Michael F.; Kanis, John, Androgen derivatives and uses thereof.
  5. Korsgaard Niels,DKX ; Piggott James Robertson ; Labroo Virender Mohan ; Bain Steven,DKX, Atrophy of skin/mucous membrane.
  6. Alan M. Polson ; Deryl D. Swanbom ; Richard L. Dunn ; Charles P. Cox ; Richard L. Norton ; Bryan K. Lowe ; Kenneth S. Peterson, Biodegradable implant precursor.
  7. Dunn Richard L. (Fort Collins CO) Tipton Arthur J. (Fort Collins CO) Southard George L. (Fort Collins CO) Rogers Jack A. (Fort Collins CO), Biodegradable polymer composition.
  8. Norton Richard L. (Fort Collins CO) Knight Stephen Michael Gregory (Fort Collins CO) Tipton Arthur J. (Birmingham AL), Biodegradable polymeric composition.
  9. Black Larry J. ; Bryant Henry U. ; Cullinan George J., Carbamate derivatives of 3-aroylbenzo[b] thiophenes.
  10. Ke Hua Zhu ; Thompson David D., Combination therapy for osteoporosis.
  11. Ke,Hua Zhu; Thompson,David D., Combination therapy for osteoporosis.
  12. Miller Chris P., Combined estrogen and antiestrogen therapy.
  13. Dunn, Richard L.; Yarborough, Cody L., Coupling syringe system and methods for obtaining a mixed composition.
  14. Podolski, Joseph S., Dosing regimes for trans-clomiphene.
  15. Dunn,Richard L., Emulsions for in-situ delivery systems.
  16. Ruenitz Peter C., Estrogen mimetics lacking reproductive tract effects.
  17. Ruenitz, Peter C., Estrogen mimetics lacking reproductive tract effects.
  18. Potter Susan M. ; Henley Edna C. ; Taylor Richard B., Hormone replacement therapy.
  19. Cullinan George J. (Trafalgar IN) Yen Terence T. (Indianapolis IN), Hypoglycemic agents.
  20. Hildebrand Keith R. ; Fowler Jan Ellen O. ; Levius Dezso K., Incontinence treatment.
  21. Bryant Henry Uhlman ; Jones Charles David ; Pennington Pamela Ann, Indene compounds having activity as SERMS.
  22. Miller Chris P. ; Collini Michael D. ; Tran Bach D., Indenoindoles and benzocarbazoles as estrogenic agents.
  23. Miller Chris P. ; Collini Michael D. ; Tran Bach D., Indenoindoles and benzocarbazoles as estrogenic agents.
  24. Chern, Rey T.; Zingerman, Joel R., Liquid polymeric compositions for controlled release of bioactive substances.
  25. Polson Alan M. ; Swanbom Deryl D. ; Dunn Richard L. ; Cox Charles P. ; Norton Richard L. ; Lowe Bryan K. ; Peterson Kenneth S., Method and composition for treating a bone tissue defect.
  26. Sodervall, Marja; Eloranta, Maire; Kalapudas, Arja, Method for the preparation of therapeutically valuable triphenylbutene derivatives.
  27. Sodervall, Marja; Eloranta, Maire; Kalapudas, Arja, Method for the preparation of therapeutically valuable triphenylbutene derivatives.
  28. Santti, Risto; Streng, Tomi, Method for the treatment or prevention of lower urinary tract symptoms.
  29. Santti, Risto; Streng, Tomi, Method for the treatment or prevention of lower urinary tract symptoms.
  30. Santti, Risto; Streng, Tomi, Method for the treatment or prevention of lower urinary tract symptoms.
  31. Gollobin Charlotte, Method for treating flushing associated with menopause.
  32. Meyers, Cal Y.; Banz, William J.; Adler, Stuart R.; Winters, Todd A.; Hou, Yuqing; Dandliker, Walter B., Method for treating or preventing prostatic conditions.
  33. McDonnell,Donald P.; Norris,John; Connor,Caroline; Wijayaratne,Ashini, Method of preventing or treating estrogen-dependent diseases and disorders.
  34. Chollet, Janet A.; Mermelstein, Fred H.; Klamerus, Bernadette, Method of treating atrophic vaginitis.
  35. Santti, Risto; Streng, Tomi; Bernoulli, Jenni; Yatkin, Emrah, Method of treating men suffering from chronic nonbacterial prostatitis with SERM compounds or aromatase inhibitors.
  36. Bitonti Alan J. (Maineville OH), Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis.
  37. Bitonti Alan J. (Maineville OH), Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis.
  38. Podolski, Joseph S, Methods and materials for the treatment of testosterone deficiency in men.
  39. Podolski, Joseph S., Methods and materials for the treatment of testosterone deficiency in men.
  40. Black, Larry J., Methods for inhibiting bone loss.
  41. Black,Larry J.; Cullinan,George J., Methods for inhibiting bone loss.
  42. Black,Larry J.; Cullinan,George J., Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride.
  43. Sodervall,Marja; Eloranta,Maire; Kalapudas,Arja; Kearton,Brian; McKenzie,Michael, Methods for the preparation of fispemifene from ospemifene.
  44. Bryant Henry U. (Indianapolis IN) Glasebrook Andrew L. (Zionsville IN) Grese Timothy A. (Indianapolis IN) Phillips David L. (Clayton IN), Methods of inhibiting CNS problems in post-menopausal women.
  45. Henry U. Bryant ; Andrew L. Glasebrook ; Timothy A. Grese ; David L. Phillips, Methods of inhibiting CNS problems in post-menopausal women.
  46. Draper,Michael W.; Black,Larry J., Methods of use for inhibiting bone loss and lowering serum cholesterol.
  47. Willson Timothy Mark, Non-steroidal ligands for the estrogen receptor.
  48. Agrawal C. Mauli ; Athanasiou Kyriacos A., Permeable compositions and methods for their preparation.
  49. Tois, Jan; Pihko, Ainoliisa; Grumann, Arne, Process for the preparation of ospemifene.
  50. Zhi, Lin, Selective androgen receptor modulators (SARMS) and uses thereof.
  51. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  52. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  53. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  54. Zhi, Lin, Selective androgen receptor modulators (SARMs) and uses thereof.
  55. Kincade Paul W. (Oklahoma City OK) Medina Kay L. (Moore OK), Selective regulation of B lymphocyte precursors by hormones.
  56. Black Larry J. (Indianapolis IN) Bryant Henry U. (Indianapolis IN) Cullinan George J. (Trafalgar IN), Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes.
  57. van As, Andre, Trans-clomiphene for metabolic syndrome.
  58. van As, Andre, Trans-clomiphene for metabolic syndrome.
  59. Podolski, Joseph S.; Wiehle, Ronald D.; Hsu, Kuang; Fontenot, Greg, Trans-clomiphene for use in cancer therapy.
  60. Podolski, Joseph S.; Wiehle, Ronald D., Trans-clomiphene metabolites and uses thereof.
  61. Steiner, Mitchell; Fisch, Harry, Treating androgen deprivation therapy induced hot flashes and bone loss in men using cis-clomiphene.
  62. Gollobin Charlotte, Treatment of hot flashes (flushing) using leucine alone or in combination with other branched chain amino acids.
  63. Södervall, Marja-Liisa; Kalapudas, Arja; Kangas, Lauri; Lammintausta, Risto; Härkönen, Pirkko; Väänänen, Kalervo, Triphenylalkene derivatives and their use as selective estrogen receptor modulators.
  64. S?dervall, Marja-Liisa; Kalapudas, Arja; Kangas, Lauri; Lammintausta, Risto; H?rk?nen, Pirkko; V??n?nen, Kalervo; Karjalainen, Arto, Triphenylalkene derivatives and their use as selective estrogen receptor modulators.
  65. Sodervall, Marja-Liisa; Kalapudas, Arja; Kangas, Lauri; Lammintausta, Risto; Harkonen, Pirkko; Vaananen, Kalervo, Triphenylalkene derivatives and their use as selective estrogen receptor modulators.
  66. Agrawal C. Mauli ; Athanasiou Kyriacos A., Variable permeability bone implants, methods for their preparation and use.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로